Société Sensei Biotherapeutics, Inc.
Actions
SNSE
US81728A1088
Recherche biotechnologique et médicale
Temps réel estimé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
1,16 USD | +13,74 % | +17,98 % | +69,08 % |
Métier
Nombre d'employés: 28
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
John Celebi
CEO | Chief Executive Officer | 52 | 01/02/18 |
Erin Colgan
DFI | Director of Finance/CFO | 43 | 01/07/20 |
Chief Tech/Sci/R&D Officer | 51 | 01/09/19 | |
Alice Drumheller
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/18 |
Michael Biega
IRC | Investor Relations Contact | - | 01/06/22 |
Stephanie Krebs
PRN | Corporate Officer/Principal | - | 01/11 |
General Counsel | - | 01/07/22 | |
Bao Le
LAW | General Counsel | - | 01/06/21 |
Corporate Officer/Principal | 44 | 01/06/22 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
William Ringo
CHM | Chairman | 78 | 08/03/22 |
John Celebi
CEO | Chief Executive Officer | 52 | 01/02/18 |
Bob Holmen
BRD | Director/Board Member | 60 | 01/01/17 |
Thomas Ricks
BRD | Director/Board Member | 70 | 01/01/15 |
Deneen Vojta
BRD | Director/Board Member | 59 | 29/01/20 |
James Peyer
BRD | Director/Board Member | 37 | 01/01/20 |
Kristian Humer
BRD | Director/Board Member | 49 | 30/07/21 |
Jessie English
BRD | Director/Board Member | 60 | 01/04/21 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 25 070 980 | 16 384 834 ( 65,35 %) | 0 | 65,35 % |
Coordonnées société
Sensei Biotherapeutics, Inc.
1405 Research Boulevard` Suite 125
20850, Rockville
+240 243 8000
http://senseibio.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+69,08 % | 25,57 M | |
-1,65 % | 102 Md | |
+2,25 % | 96,09 Md | |
+2,13 % | 22,28 Md | |
-16,50 % | 21,4 Md | |
-8,79 % | 18,14 Md | |
-39,98 % | 17,02 Md | |
-13,80 % | 16,09 Md | |
+5,42 % | 13,83 Md | |
+33,49 % | 11,97 Md |
- Bourse
- Actions
- Action SNSE
- Société Sensei Biotherapeutics, Inc.